CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 397 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,494 | -59.8% | 143,067 | -50.3% | 0.01% | -52.2% |
| Q2 2023 | $16,157 | -27.9% | 287,800 | -41.9% | 0.02% | -23.3% |
| Q1 2023 | $22,394 | -30.0% | 495,103 | -37.1% | 0.03% | -31.8% |
| Q4 2022 | $31,975 | -99.9% | 786,600 | +32.6% | 0.04% | -20.0% |
| Q3 2022 | $38,772,000 | +12.2% | 593,300 | +4.3% | 0.06% | +34.1% |
| Q2 2022 | $34,560,000 | -21.6% | 568,700 | -19.0% | 0.04% | -21.2% |
| Q1 2022 | $44,083,000 | +0.5% | 702,300 | +21.3% | 0.05% | -5.5% |
| Q4 2021 | $43,865,000 | +192.4% | 578,842 | +370.2% | 0.06% | +189.5% |
| Q1 2021 | $15,001,000 | -36.0% | 123,110 | -19.6% | 0.02% | -24.0% |
| Q4 2020 | $23,456,000 | -28.9% | 153,200 | -61.2% | 0.02% | -24.2% |
| Q3 2020 | $33,013,000 | +21.9% | 394,700 | +7.1% | 0.03% | +43.5% |
| Q2 2020 | $27,093,000 | +25.5% | 368,658 | -27.6% | 0.02% | +9.5% |
| Q1 2020 | $21,594,000 | -10.1% | 509,175 | +29.0% | 0.02% | +16.7% |
| Q4 2019 | $24,031,000 | +1391.7% | 394,564 | +904.0% | 0.02% | +1700.0% |
| Q3 2019 | $1,611,000 | +394.2% | 39,300 | +244.7% | 0.00% | – |
| Q4 2018 | $326,000 | -96.8% | 11,400 | -93.3% | 0.00% | -100.0% |
| Q2 2018 | $10,054,000 | – | 171,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |